Home/Centessa Pharmaceuticals/Gregory Weinhoff, MD, MBA
GW

Gregory Weinhoff, MD, MBA

Chief Business Officer

Centessa Pharmaceuticals

Therapeutic Areas

Centessa Pharmaceuticals Pipeline

DrugIndicationPhase
ORX750Narcolepsy Type 1 (NT1)Phase 2
ORX142Neurological & Neurodegenerative DisordersPreclinical / Phase 1
ORX489Neuropsychiatric DisordersPreclinical
LockBody® PlatformOncologyDiscovery